世界のPD-1＆PD-L1抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global PD-1 and PD-L1 Antibody Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4667
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、PD-1＆PD-L1抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・PD-1＆PD-L1抗体の市場動向
・企業の競争状況、市場シェア
・PD-1＆PD-L1抗体の種類別市場規模と予測2016-2027（PD-1阻害剤、PD-L1阻害剤）
・PD-1＆PD-L1抗体の用途別市場規模と予測2016-2027（固形腫瘍、血液関連腫瘍）
・PD-1＆PD-L1抗体の北米市場規模2016-2027（アメリカ、カナダ）
・PD-1＆PD-L1抗体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・PD-1＆PD-L1抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・PD-1＆PD-L1抗体の中南米市場規模2016-2027（メキシコ、ブラジル）
・PD-1＆PD-L1抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Bristol-Myers Squibb、F. Hoffmann-La Roche、Merck、Pfizer、Roche、Novartis、Jiangsu HengRui Medicine、Innovent、Eli Lilly、GlaxoSmithKline）
・結論

Market Analysis and Insights: Global PD-1 and PD-L1 Antibody Market
The global PD-1 and PD-L1 Antibody market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PD-1 and PD-L1 Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PD-1 and PD-L1 Antibody market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PD-1 and PD-L1 Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PD-1 and PD-L1 Antibody market.

Global PD-1 and PD-L1 Antibody Scope and Market Size
PD-1 and PD-L1 Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PD-1 and PD-L1 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PD-1 inhibitor
PD-L1 inhibitor

Segment by Application
Solid Tumors
Blood-related Tumors

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Bristol-Myers Squibb
F. Hoffmann-La Roche
Merck
Pfizer
Roche
Novartis
Jiangsu HengRui Medicine
Innovent
Eli Lilly
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PD-1 inhibitor
1.2.3 PD-L1 inhibitor
1.3 Market by Application
1.3.1 Global PD-1 and PD-L1 Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global PD-1 and PD-L1 Antibody Market Perspective (2016-2027)
2.2 PD-1 and PD-L1 Antibody Growth Trends by Regions
2.2.1 PD-1 and PD-L1 Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 PD-1 and PD-L1 Antibody Historic Market Share by Regions (2016-2021)
2.2.3 PD-1 and PD-L1 Antibody Forecasted Market Size by Regions (2022-2027)
2.3 PD-1 and PD-L1 Antibody Industry Dynamic
2.3.1 PD-1 and PD-L1 Antibody Market Trends
2.3.2 PD-1 and PD-L1 Antibody Market Drivers
2.3.3 PD-1 and PD-L1 Antibody Market Challenges
2.3.4 PD-1 and PD-L1 Antibody Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue
3.1.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue (2016-2021)
3.1.2 Global PD-1 and PD-L1 Antibody Revenue Market Share by Players (2016-2021)
3.2 Global PD-1 and PD-L1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PD-1 and PD-L1 Antibody Revenue
3.4 Global PD-1 and PD-L1 Antibody Market Concentration Ratio
3.4.1 Global PD-1 and PD-L1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-1 and PD-L1 Antibody Revenue in 2020
3.5 PD-1 and PD-L1 Antibody Key Players Head office and Area Served
3.6 Key Players PD-1 and PD-L1 Antibody Product Solution and Service
3.7 Date of Enter into PD-1 and PD-L1 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PD-1 and PD-L1 Antibody Breakdown Data by Type
4.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Type (2016-2021)
4.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2022-2027)

5 PD-1 and PD-L1 Antibody Breakdown Data by Application
5.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Application (2016-2021)
5.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America PD-1 and PD-L1 Antibody Market Size (2016-2027)
6.2 North America PD-1 and PD-L1 Antibody Market Size by Type
6.2.1 North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
6.2.2 North America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
6.2.3 North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
6.3 North America PD-1 and PD-L1 Antibody Market Size by Application
6.3.1 North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
6.3.2 North America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
6.3.3 North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
6.4 North America PD-1 and PD-L1 Antibody Market Size by Country
6.4.1 North America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
6.4.2 North America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe PD-1 and PD-L1 Antibody Market Size (2016-2027)
7.2 Europe PD-1 and PD-L1 Antibody Market Size by Type
7.2.1 Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
7.2.2 Europe PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
7.2.3 Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
7.3 Europe PD-1 and PD-L1 Antibody Market Size by Application
7.3.1 Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
7.3.2 Europe PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
7.3.3 Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
7.4 Europe PD-1 and PD-L1 Antibody Market Size by Country
7.4.1 Europe PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
7.4.2 Europe PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size (2016-2027)
8.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type
8.2.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application
8.3.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region
8.4.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America PD-1 and PD-L1 Antibody Market Size (2016-2027)
9.2 Latin America PD-1 and PD-L1 Antibody Market Size by Type
9.2.1 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
9.2.2 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
9.2.3 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
9.3 Latin America PD-1 and PD-L1 Antibody Market Size by Application
9.3.1 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
9.3.2 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
9.3.3 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
9.4 Latin America PD-1 and PD-L1 Antibody Market Size by Country
9.4.1 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
9.4.2 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size (2016-2027)
10.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type
10.2.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application
10.3.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country
10.4.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca PD-1 and PD-L1 Antibody Introduction
11.1.4 AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Antibody Introduction
11.2.4 Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Introduction
11.3.4 F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck PD-1 and PD-L1 Antibody Introduction
11.4.4 Merck Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer PD-1 and PD-L1 Antibody Introduction
11.5.4 Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche PD-1 and PD-L1 Antibody Introduction
11.6.4 Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis PD-1 and PD-L1 Antibody Introduction
11.7.4 Novartis Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Jiangsu HengRui Medicine
11.8.1 Jiangsu HengRui Medicine Company Details
11.8.2 Jiangsu HengRui Medicine Business Overview
11.8.3 Jiangsu HengRui Medicine PD-1 and PD-L1 Antibody Introduction
11.8.4 Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.8.5 Jiangsu HengRui Medicine Recent Development
11.9 Innovent
11.9.1 Innovent Company Details
11.9.2 Innovent Business Overview
11.9.3 Innovent PD-1 and PD-L1 Antibody Introduction
11.9.4 Innovent Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.9.5 Innovent Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly PD-1 and PD-L1 Antibody Introduction
11.10.4 Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline PD-1 and PD-L1 Antibody Introduction
11.11.4 GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PD-1 inhibitor
Table 3. Key Players of PD-L1 inhibitor
Table 4. Global PD-1 and PD-L1 Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global PD-1 and PD-L1 Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global PD-1 and PD-L1 Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global PD-1 and PD-L1 Antibody Market Share by Regions (2016-2021)
Table 8. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global PD-1 and PD-L1 Antibody Market Share by Regions (2022-2027)
Table 10. PD-1 and PD-L1 Antibody Market Trends
Table 11. PD-1 and PD-L1 Antibody Market Drivers
Table 12. PD-1 and PD-L1 Antibody Market Challenges
Table 13. PD-1 and PD-L1 Antibody Market Restraints
Table 14. Global PD-1 and PD-L1 Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global PD-1 and PD-L1 Antibody Market Share by Players (2016-2021)
Table 16. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Antibody as of 2020)
Table 17. Ranking of Global Top PD-1 and PD-L1 Antibody Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by PD-1 and PD-L1 Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PD-1 and PD-L1 Antibody Product Solution and Service
Table 21. Date of Enter into PD-1 and PD-L1 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 24. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2016-2021)
Table 25. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global PD-1 and PD-L1 Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2016-2021)
Table 29. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 32. North America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 34. North America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca PD-1 and PD-L1 Antibody Product
Table 64. AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb PD-1 and PD-L1 Antibody Product
Table 69. Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. F. Hoffmann-La Roche Company Details
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Product
Table 74. F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck PD-1 and PD-L1 Antibody Product
Table 79. Merck Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer PD-1 and PD-L1 Antibody Product
Table 84. Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche PD-1 and PD-L1 Antibody Product
Table 89. Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis PD-1 and PD-L1 Antibody Product
Table 94. Novartis Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Jiangsu HengRui Medicine Company Details
Table 97. Jiangsu HengRui Medicine Business Overview
Table 98. Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 99. Jiangsu HengRui Medicine Recent Development
Table 100. Innovent Company Details
Table 101. Innovent Business Overview
Table 102. Innovent PD-1 and PD-L1 Antibody Product
Table 103. Innovent Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 104. Innovent Recent Development
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly PD-1 and PD-L1 Antibody Product
Table 108. Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 109. Eli Lilly Recent Development
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline PD-1 and PD-L1 Antibody Product
Table 113. GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million)
Table 114. GlaxoSmithKline Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-1 and PD-L1 Antibody Market Share by Type: 2020 VS 2027
Figure 2. PD-1 inhibitor Features
Figure 3. PD-L1 inhibitor Features
Figure 4. Global PD-1 and PD-L1 Antibody Market Share by Application: 2020 VS 2027
Figure 5. Solid Tumors Case Studies
Figure 6. Blood-related Tumors Case Studies
Figure 7. PD-1 and PD-L1 Antibody Report Years Considered
Figure 8. Global PD-1 and PD-L1 Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global PD-1 and PD-L1 Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global PD-1 and PD-L1 Antibody Market Share by Regions: 2020 VS 2027
Figure 11. Global PD-1 and PD-L1 Antibody Market Share by Regions (2022-2027)
Figure 12. Global PD-1 and PD-L1 Antibody Market Share by Players in 2020
Figure 13. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Antibody as of 2020
Figure 14. The Top 10 and 5 Players Market Share by PD-1 and PD-L1 Antibody Revenue in 2020
Figure 15. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2016-2021)
Figure 16. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2022-2027)
Figure 17. North America PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 19. North America PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 20. North America PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 21. United States PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 25. Europe PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 26. Europe PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 27. Germany PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 35. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 36. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Region (2016-2027)
Figure 37. China PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 45. Latin America PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 46. Latin America PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 47. Mexico PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Type (2016-2027)
Figure 51. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Application (2016-2027)
Figure 52. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Country (2016-2027)
Figure 53. Turkey PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 63. Jiangsu HengRui Medicine Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 64. Innovent Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global PD-L1 Biomarker Testing Market Size, Status and Forecast 2021-2027
QFJ1-4669 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、PD-L1バイオマーカー検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-L1 IHC 22C3アッセイ、PD-L1 IHC 28-8アッセイ、PD-L1（SP142）アッセイ、PD-L1（S...

世界のPD-1＆PD-L1免疫療法市場規模・現状・予測（2021年-2027年）

Global PD-1 and PD-L1 Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-4668 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、PD-1＆PD-L1免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の抗ニューロフィラメントL抗体市場規模・現状・予測（2021年-2027年）

Global Anti Neurofilament L Antibody Market Size, Status and Forecast 2021-2027
QFJ1-3816 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、抗ニューロフィラメントL抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マウス抗ニューロフィラメントL抗体、ウサギ抗ニューロフィラメントL抗体、その他）、用途別市場規模（学術研究機関、製薬＆バイオ...

世界のウサギ抽出抗DPH5抗体市場規模・現状・予測（2021年-2027年）

Global Anti-DPH5 Antibody Produced In Rabbit Market Size, Status and Forecast 2021-2027
QFJ1-3827 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウサギ抽出抗DPH5抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、ポリクローナル抗体）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の抗核抗体（ANA）検査市場規模・現状・予測（2021年-2027年）

Global Anti-nuclear Antibody (ANA) Testing Market Size, Status and Forecast 2021-2027
QFJ1-5081 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、抗核抗体（ANA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（間接蛍光抗体法、酵素免疫測定法（ELISA）、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の抗核抗体検査市場規模・現状・予測（2021年-2027年）

Global Anti-Nuclear Antibody Test Market Size, Status and Forecast 2021-2027
QFJ1-3832 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、抗核抗体検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISA、間接蛍光抗体法、マルチプレックス試験）、用途別市場規模（全身性エリテマトーデス、シェーグレン症候群、関節リウマチ、強皮症、多発性...

世界のがんモノクローナル抗体提携条件＆契約市場規模・現状・予測（2021年-2027年）

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Size, Status and Forecast 2021-2027
QFJ1-3957 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、がんモノクローナル抗体提携条件＆契約の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（資産購入、共同研究開発、合弁事業、ライセンス供与、その他）、用途別市場規模（製薬産業、バイオテクノロジー、医療、教育...

世界の狂犬病モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global Rabies Monoclonal Antibody Market Size, Status and Forecast 2021-2027
QFJ1-5502 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、狂犬病モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カテゴリーII暴露、カテゴリーIII暴露）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

抗体薬物複合体（ADC）のグローバル市場2021

Global Antibody-drug Conjugates Sales Market Report 2021
QAF27563 2021年3月23日 131Pages
本市場調査資料では、世界の抗体薬物複合体（ADC）市場について種類別（アドセトリス、カドサイラ）、用途別（乳がん、リンパ腫）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの...

モノクローナル抗体診断試薬のグローバル市場2021

Global Monoclonal Antibody Diagnostic Reagents Sales Market Report 2021
QAF27793 2021年4月13日 138Pages
本市場調査資料では、世界のモノクローナル抗体診断試薬市場について種類別（酵素免疫測定法、ドット免疫金濾過アッセイ、二重抗原サンドイッチ化学発光法、組換え免疫ブロットアッセイ）、用途別（腫瘍モニタリング、ウイルス性肝炎診断、性感染症診断、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、...

世界の抗ニューロフィラメントL抗体市場規模・現状・予測（2021年-2027年） Neurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon. Market Analysis and Insights: Global Anti Neurofilament L Antibody Market The …
世界のウサギ抽出抗DPH5抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-DPH5 Antibody Produced In Rabbit Market The global Anti-DPH5 Antibody Produced In Rabbit market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
世界の抗核抗体（ANA）検査市場規模・現状・予測（2021年-2027年） Antinuclear antibodies (ANA) are a group of autoantibodies produced by a person's immune system when it fails to adequately distinguish between "self" and "nonself." The ANA testing detects these autoantibodies in the blood. Market Analysis and Insights: Global Anti-nuclear Antibody (ANA) Testing Ma…
世界の抗核抗体検査市場規模・現状・予測（2021年-2027年） Antinuclear antibodies (ANA) are a group of autoantibodies produced by a person's immune system when it fails to adequately distinguish between "self" and "nonself." The ANA test detects these autoantibodies in the blood. Market Analysis and Insights: Global Anti-Nuclear Antibody Test Market The glo…
世界の狂犬病モノクローナル抗体市場規模・現状・予測（2021年-2027年） Anti-rabies virus monoclonal antibody is a passive immune preparation, which has the same or better neutralizing effect as rabies immunoglobulin. The development of anti-rabies virus monoclonal antibodies to replace traditional human immunoglobulin and immune antiserum products is an important direc…